AlphAIAlphAI — Financial news for AI agents
MarketBeatMAR 313 min read$SLRC

Short Interest in SLR Investment Corp. (NASDAQ:SLRC) Expands By 23.8%

SLR Investment Corp. (NASDAQ:SLRC) experienced a 23.8% increase in short interest during March, reaching 609,038 shares, which represents about 1.2% of its shares outstanding. Despite this, the company maintains a high dividend yield of 11.7% with a $0.41 quarterly dividend. Analyst ratings are mixed, leading to a consensus "Hold" rating, while an insider recently increased their stake by purchasing 25,000 shares.

Original reporting
MarketBeat · MarketBeat
Published Mar 31, 2026, 3:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 31, 2026, 4:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Short Interest in SLR Investment Corp. (NASDAQ:SLRC) Expands By 23.8% — source image
Source · MarketBeat
Decision brief

The 30-second read

$SLRCNeutralMed
01

Why it matters

The recent short interest surge could pressure the stock price, but dividend stability and insider activity provide support.

02

Market read

The news is moderately relevant for traders focusing on financial sector stocks with high dividend yields and short interest activity.

03

What to watch

Broader market conditions and interest rate environment could influence stock movement beyond short interest data.

Timing: short-term (next 1-3 months)

Background

SLR Investment Corp. has experienced fluctuating short interest, reflecting changing investor sentiment amid market volatility.

Company-level read

Ticker impact

$SLRCNeutralMedium confidence
Context

Recent increase in short interest and high dividend yield suggest mixed signals for investors.

Expected impact

Potential short-term decline followed by stabilization or slight rebound.

Evidence & confidence

The significant short interest increase suggests caution; however, strong dividends and insider activity could support the stock price.

Market effects

Sector

Financial sector may experience increased volatility due to short interest shifts.

Regional

Limited regional impact; specific to US financial stocks.

Global

Low; focused on US market and specific to SLRC.

Counterpoint

What could challenge this read

The increase in short interest may be a temporary correction; the high dividend yield and insider buying suggest underlying strength.

Key entities

  • Company
    SLR Investment Corp.

    A publicly traded business development company (BDC) providing investment management services.

Read at source← All news

Related articles

SEP 11
$BAHighAI 9/10

Boeing wins $13.4 billion contract modification from US military

Boeing Co. received a $13.4 billion contract modification from the U.S. Department of War, raising the total contract value to $19.1 billion. The contract, originally awarded in 2019, includes Foreign Military Sales work for Japan, Israel, and future partners. Work will be completed in Seattle by April 28, 2035, with no funds allocated at the time of the award.

investing.com2 min
SEP 11
$CFGMed

Fitch upgrades Citizens Financial rating on profitability

Fitch upgraded Citizens Financial Group (CFG) and Citizens Bank to 'A-' from 'BBB+', citing improved earnings and profitability. The upgrade reflects margin expansion, stable credit costs, and growth in fee-generating businesses. CFG's non-interest income was 28% of revenue in H1 2026, with wealth management and capital markets revenue up 16% and 52% YoY, respectively. The impaired loan ratio was stable at 1.8%, and the CET1 ratio was 10.4% in Q2 2026.

investing.com2 min
SEP 11
$AZNHighAI 8/10

AstraZeneca breast cancer drug fails late-stage trial goal

AstraZeneca's breast cancer drug, Etcamah, failed to meet the primary endpoint in a late-stage trial, causing a 3% drop in its U.S.-listed shares. The trial tested the drug in combination with palbociclib for advanced breast cancer. AstraZeneca plans to share full trial data later. The FDA recently granted accelerated approval for Etcamah with certain targeted cancer medicines.

investing.com2 min
SEP 11
$HRLMed

S&P Global downgrades Hormel Foods outlook on high leverage

S&P Global Ratings revised Hormel Foods' outlook to negative from stable, citing high leverage at 1.8x, above expectations. The firm forecasts modest improvement to 1.7x in 2027 and 1.6x in 2028. Hormel's EBITDA margins have fallen to under 11% due to rising input costs and operational issues. The company is divesting lower-margin assets, but S&P notes these have not significantly reduced debt. A lower rating is possible if leverage does not improve.

investing.com2 min
SEP 11
$MSFTLow

Microsoft communications boss Frank Shaw leaving after nearly 30 years

Microsoft's communications boss Frank Shaw is leaving after nearly 30 years, according to a memo. Shaw, 64, has been in his role for 17 years and played a major role in shaping Microsoft's external communications. His departure comes as Microsoft undergoes changes, focusing on AI and cloud computing. Microsoft's Azure cloud business crossed $100 billion in annual revenue, driven by AI demand.

fortune.com2 min